Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)

Clinical trial NCT00350779 · COMPLETED

Trial details

NCT number: NCT00350779
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2006-06-12
Primary completion: 2007-09-25
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.